US Patent 10493035 Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
Patent 10493035 was granted and assigned to Global Blood Therapeutics on December, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 12, 2017
Date of Patent
December 3, 2019
Patent Applicant
Patent Application Number
15782381
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10493035 Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
